Brief: Virpax Pharmaceuticals Reports Third Quarter Results
09/11/2022 14:27
Nov 9 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2022 THIRD QUARTER RESULTS
* VIRPAX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.65
* VIRPAX PHARMACEUTICALS INC - AT SEPTEMBER 30, 2022,
COMPANY HAD
CASH OF APPROXIMATELY $20.6 MILLION
Source text for Eikon: ID:nBw657d6fa
Further company coverage: VRPX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study